Chemical Structure (Elacestrant 01)
Orserdu Tablet, Film Coated
Product Images NDC 72187-0102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orserdu (NDC 72187-0102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stemline Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Elacestrant 02)
This is a graph showing the probability of progression-free survival (%) over time (months) for two treatments: T-Ecestrant and Fulvostrant, an Aromatase Inhibitor. The graph shows the time across the X-axis and the probability of progression-free survival across the Y-axis.*
Orserdu Bottle Label (86mg)
This is a description of a medication called elacestrant, which comes in tablet form with a dosage of 86 mg. The tablets are manufactured by Stemline Therapeutics and are for prescription use only. The packaging includes the company's contact information, manufacturing date, and recommended storage conditions. The medication should be kept out of reach of children.*
Orserdu Bottle Label (345mg)
This is a description of a medication named "Elacestrant" manufactured by Stemline Therapeutics, Inc. The medication comes in tablet form, with each tablet containing 345 mg of Elacestrant, which is equivalent to 400 mg of Elacestrant dihydrochloride. It is recommended for use only as per the prescription. The medication should be stored at 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). The NDC code for this medication is 72187-0102-3, and it is recommended to keep it out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
